Your browser doesn't support javascript.
loading
Defining the blanking period, using continuous ECG monitoring, after cryoballoon pulmonary vein isolation.
Musat, Dan L; Milstein, Nicolle S; Saberito, Matthew; Bhatt, Advay; Habibi, Mohammadali; Sichrovsky, Tina C; Preminger, Mark W; Shaw, Richard E; Mittal, Suneet.
Afiliação
  • Musat DL; Valley Hospital and the Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, New Jersey.
  • Milstein NS; Valley Hospital and the Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, New Jersey.
  • Saberito M; Valley Hospital and the Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, New Jersey.
  • Bhatt A; Valley Hospital and the Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, New Jersey.
  • Habibi M; Valley Hospital and the Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, New Jersey.
  • Sichrovsky TC; Valley Hospital and the Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, New Jersey.
  • Preminger MW; Valley Hospital and the Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, New Jersey.
  • Shaw RE; Valley Hospital and the Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, New Jersey.
  • Mittal S; Valley Hospital and the Snyder Center for Comprehensive Atrial Fibrillation, Ridgewood, New Jersey. Electronic address: mittsu@valleyhealth.com.
Heart Rhythm ; 21(5): 530-537, 2024 May.
Article em En | MEDLINE | ID: mdl-38350520
ABSTRACT

BACKGROUND:

Pulmonary vein isolation (PVI) is the cornerstone of atrial fibrillation (AF) ablation. A blanking period (BP) of 3 months is used in clinical trials and practice. However, the optimal BP duration after PVI remains undefined.

OBJECTIVE:

The aim of this study was to objectively define, using continuous monitoring by an implantable loop recorder, the optimal BP duration after cryoballoon PVI.

METHODS:

We enrolled consecutive patients who had cryoballoon PVI and an implantable loop recorder. We determined the time of the last confirmed episode of AF within the blanking period. This was then correlated with AF recurrence in the first year after ablation.

RESULTS:

There were 210 patients (66 ± 9 years; 138 [66%] male; 116 [55%] paroxysmal AF; CHA2DS2-VASc score, 2.5 ± 1.6). We defined 4 distinct groups based on the last AF episode within the BP no AF days 0-90 (n = 96 [46%]) and last AF 0-30 days (n = 46 [22%]), 31-60 days (n = 18 [9%]), and 61-90 days (n = 50 [24%]). After the 3-month BP, 101 (48%) patients had AF recurrence at 160 ± 86 days. Compared with patients with no AF in the BP, those with recurrent AF and AF burden >0% 30 days after ablation had a significantly greater AF recurrence during long-term follow-up (P = .001).

CONCLUSION:

Our data show that the approximately one-third of patients in whom AF occurs and who have a burden of >0% after the first month that follows PVI are at significantly higher risk of long-term recurrent AF. We therefore suggest that the blanking period be limited to a month after cryoballoon PVI.
Assuntos
Palavras-chave

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Veias Pulmonares / Fibrilação Atrial / Criocirurgia Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Heart Rhythm Ano de publicação: 2024 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Veias Pulmonares / Fibrilação Atrial / Criocirurgia Limite: Aged / Female / Humans / Male / Middle aged Idioma: En Revista: Heart Rhythm Ano de publicação: 2024 Tipo de documento: Article